XYL

What Facts Should You Know About Xylem?

Shares of Industrials sector company Xylem moved 1.9% today, and are now trading at a price of $96.99. The large-cap stock's daily volume was 1,018,491 compared to its average volume of 1,395,625. The S&P 500 index returned a 1.0% performance.

Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. The company is based in Washington and has 22,000 full time employees. Its market capitalization is $23,358,003,200. Xylem currently offers its equity investors a dividend that yields 1.3% per year.

10 analysts are following Xylem and have set target prices ranging from $105.0 to $135.0 per share. On average, they have given the company a rating of buy. At today's prices, XYL is trading -21.85% away from its average analyst target price of $124.1 per share.

Over the last year, XYL shares have gone down by -0.0%, which represents a difference of -10.0% when compared to the S&P 500. The stock's 52 week high is $118.58 per share and its 52 week low is $84.16.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023-02-24 596,000 -208,000 804,000 7.77
2022-02-25 538,000 -208,000 746,000 -25.92
2021-02-26 824,000 -183,000 1,007,000 -5.45
2020-02-28 839,000 -226,000 1,065,000 29.4
2019-02-22 586,000 -237,000 823,000 -3.74
2018-02-23 686,000 -169,000 855,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS